Bio Medica LaboratoriesNSE:BMLL +0.49%14 Pretax Margin % is 34.41% as of Mar. 2025, which is 44% above its 10-year median of 23.94. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Bio Medica Laboratories ranks better than 96.08% on this metric.
The historical rank and industry rank for Bio Medica Laboratories's Pretax Margin % or its related term are showing as below:
NSE:BMLL'
s Pretax Margin % Range Over the Past 10 Years
Min: 2.79 Med: 23.94 Max: 34.41
Current: 34.41
NSE:BMLL's Pretax Margin % is ranked better than 96.08% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.4
vs NSE:BMLL: 34.41
Bio Medica Laboratories (NSE:BMLL) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Bio Medica Laboratories Pretax Margin % Related Terms
Bio Medica Laboratories Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Medica Laboratories Pretax Margin % Chart
Bio Medica Laboratories Annual Data
Trend
Mar23
Mar24
Mar25
Pretax Margin %
2.79
23.94
34.41
Bio Medica Laboratories Semi-Annual Data
Mar23
Mar24
Mar25
Pretax Margin %
2.79
23.94
34.41
NSE:BMLL vs ISRG, BDX, MDLN: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Bio Medica Laboratories's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Medica Laboratories Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio Medica Laboratories's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Bio Medica Laboratories's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Medica Laboratories (NSE:BMLL) has a Pretax Margin % of 34.41% as of Mar. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bio Medica Laboratories and its competitors. This is 44% above median its historical median of 23.94. Over the past decade, Bio Medica Laboratories' Pretax Margin % has ranged from 2.79 to 34.41. According to the industry distribution chart, Bio Medica Laboratories ranks #32 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 3.9%.
Is Bio Medica Laboratories' Pretax Margin % too high?
Bio Medica Laboratories' current Pretax Margin % of 34.41% is 44% above median its 10-year median of 23.94. Over the past 10 years, this metric has ranged from a low of 2.79 to a high of 34.41. The Medical Devices & Instruments industry median Pretax Margin % is 2.40. Bio Medica Laboratories' value of 34.41% is 1333.8% above this industry median. Based on the distribution chart, Bio Medica Laboratories ranks #32 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Pretax Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bio Medica Laboratories ranks #32 out of 817 companies for Pretax Margin %. This places Bio Medica Laboratories in the top 4% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.40. Bio Medica Laboratories' value of 34.41% is 1333.8% above this benchmark. Historically, Bio Medica Laboratories' own Pretax Margin % has ranged from 2.79 to 34.41 over the past decade. While the company's 10-year median is 23.94 vs. the industry median of 2.40, Bio Medica Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.40, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio Medica Laboratories's current Pretax Margin % of 34.41% is 1333.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Bio Medica Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Medica Laboratories's current Pretax Margin % is 34.41%, which is 44% above median its own 10-year median of 23.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Pretax Margin % of 34.41%. The current Pretax Margin % is 34.41%, which is 44% above median its 10-year median of 23.94 and 1333.8% above the Medical Devices & Instruments industry median of 2.40. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Pretax Margin % is 34.41% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score
Get the complete analysis for NSE:BMLL
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BMLL has been successfully added to your 